A Propensity Score Cohort Study on the Long-Term Safety and Efficacy of Sleeve Gastrectomy in Patients Older Than Age 60
Molero, Judith (Hospital Clínic i Provincial de Barcelona)
Olbeyra, Romina (Institut d'Investigacions Biomèdiques August Pi i Sunyer)
Vidal, Josep (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas)
Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Cañizares, Silvia (Hospital Clínic i Provincial de Barcelona)
Andreu, Alba (Hospital Clínic i Provincial de Barcelona)
Ibarzabal, Ainitze (Hospital Clínic i Provincial de Barcelona)
Jiménez, Amanda (Institut d'Investigacions Biomèdiques August Pi i Sunyer)
de Hollanda, Ana (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición)
Moizé, Violeta (Hospital Clínic i Provincial de Barcelona)
Flores, Lilliam (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas)

Data:	2020
Resum:	Bariatric surgery (BS) in older obese subjects (>60 years of age) has risen in the past decade and will continue to rise in the coming years due to ageing of the population. To evaluate the short- (12 months) and long-term (60 months) results of laparoscopic sleeve gastroscopy (LSG) in patients older than age 60. We performed a retrospective review of patients prospectively included in a database from January 2007 to December 2013. All patients >60 [older group (OG)] who had undergone LSG were included. The control group (CG) included patients aged 50 to 59 years who had undergone LSG during the same period. 116 (8. 4 % of total surgery) and 145 patients were included in the OG and CG, respectively. BS in patients >60 years increased from 2. 4% in 2003 to 14% in the last 2 years of the study. After inverse probability of treatment weighting (IPTW) analysis, all absolute standardized differences were <0. 15. A 60-month follow-up was attained in 90% of patients in the OG and 74% in the CG. There were no significant differences in postoperative complications between the two groups. At 12 and 60 months after LSG, both groups achieved a similar body mass index. There was no statistical difference in the percentage of resolution of type 2 diabetes, hypertension, dyslipidemia, and SAHS between the two groups. In both groups, all the nutritional parameters evaluated remained within the normal range throughout the study. LSG provides acceptable outcomes and is safe in older adults indicating that age should not be a limitation to perform BS in this population.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	Journal of Obesity, Vol. 2020 (july 2020) , ISSN 2090-0716

DOI: 10.1155/2020/8783260
PMID: 32802499

6 p, 390.7 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats